←Back to Expert Scholars
Translational Medicine / 转化医学RCC, Urothelial Cancer
Elizabeth Plimack
MD, MS
🏢Fox Chase Cancer Center🌐USA
Chief Division of Genitourinary Medical Oncology
70
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Elizabeth Plimack has led pivotal immunotherapy combination trials in kidney and urothelial cancer including KEYNOTE-426. Her research helped establish pembrolizumab plus axitinib as a standard in advanced RCC. She directs GU medical oncology at Fox Chase and is active in rare RCC subtypes.
Share:
🧪Research Fields 研究领域
RCC
immunotherapy
combination therapy
clinical trials
GU oncology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Elizabeth Plimack 的研究动态
Follow Elizabeth Plimack's research updates
留下邮箱，当我们发布与 Elizabeth Plimack（Fox Chase Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment